Meloxicam Capsules (Meloxicam)

Adult dose

1. Acute exacerbation of osteoarthritis (degenerative arthritis): ○ Adults: Administer 7.5 mg of meloxicam orally once daily. If symptoms do not improve, the dose may be increased to 15 mg daily as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer 15 mg of this medicine orally once daily. The dose may be reduced to 7.5 mg daily depending on response to treatment. Do not administer more than 15 mg of this medicine per day; take with water or another beverage during a meal. ○ In older adults or those at increased risk of adverse reactions, treatment is usually initiated at a dose of 7.5 mg daily. ○ Patients with severe renal failure receiving hemodialysis should not receive more than 7.5 mg daily.

This medication should be discussed with a doctor or pharmacist before use for individuals who regularly consume more than three drinks of alcohol per day, as it may cause gastrointestinal bleeding. Non-steroidal anti-inflammatory drugs, including this medication, carry a risk of exacerbating cardiovascular issues. Individuals with a history of heart disease or risk factors should be particularly cautious due to the increased risk of serious cardiovascular events such as myocardial infarction or stroke. This medication can cause serious problems such as gastrointestinal bleeding, ulcers, and perforation. Elderly patients and those with a history of gastrointestinal disorders should closely monitor for gastrointestinal symptoms during treatment. Serious skin reactions or allergic reactions can occur, so if any unusual skin symptoms arise, discontinue use immediately and consult a doctor. This medication can affect kidney function, so caution is advised for those with kidney disease or those taking related medications. Women planning to become pregnant or who may be pregnant should avoid using this medication and it should not be taken during pregnancy. The risk of bleeding may increase if this medication is taken in conjunction with other non-steroidal anti-inflammatory drugs or aspirin, so co-administration should be avoided. Long-term use requires regular blood tests and liver and kidney function monitoring. If any unusual symptoms occur, consult a doctor immediately. Caution is needed when driving or operating machinery as drowsiness or dizziness may occur. Children and individuals with certain conditions, especially those with a history of gastrointestinal bleeding, severe liver or kidney disease, or advanced heart failure, should not use this medication. It is advisable to avoid alcohol consumption during treatment and seek medical attention immediately in case of overdose.

Gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, bleeding from the stomach or intestines, ulcer, perforation, exfoliative dermatitis, mucocutaneous syndrome, toxic epidermal necrolysis, anaphylaxis reactions, interstitial nephritis, glomerulonephritis, renal medullary necrosis, nephrotic syndrome, elevated serum transaminases, increased liver function tests, increased plasma creatinine, increased blood urea nitrogen, aplastic anemia, bone marrow suppression, changes in blood cell counts, leukopenia, thrombocytopenia, anemia, decreased plasma iron, decreased hemoglobin, decreased hematocrit, increased neutrophils, increased eosinophils, increased basophils, increased monocytes, agranulocytosis, anaphylaxis, anaphylactoid reaction, malaise, confusion, loss of orientation, mood changes, mood disorders, insomnia, nightmares, anxiety, increased appetite, depression, irritability, dizziness, drowsiness, headache, cranial pressure, fatigue, lethargy, taste dysfunction, mental confusion, seizures, sensory disturbances, tremors, visual disturbances, visual impairment, conjunctivitis, foreign body sensation in the eye, subconjunctival hemorrhage, tinnitus, palpitations, elevated blood pressure, flushing, facial flushing, arrhythmia, tachycardia, hypotension, hypertension, myocardial infarction, angina, heart failure, vasculitis, cough, upper respiratory infection, asthma, bronchospasm, dyspnea, allergic reactions, dyspepsia, nausea, vomiting, abdominal pain, constipation, abdominal distension, diarrhea, loss of appetite, peptic ulcer, occult gastrointestinal bleeding, gross gastrointestinal bleeding, stomatitis, gastritis, esophagitis, belching, dry mouth, thirst, angular cheilitis, occult blood in stool, gastric perforation, colitis, pancreatitis, melena, perforated peptic ulcer, hepatitis, elevated plasma transaminase levels, elevated bilirubin, jaundice, hepatic failure, skin rash, urticaria, pruritus, angioedema, vesicular dermatitis, erythema multiforme, photosensitive reactions, contact dermatitis, fixed drug eruption, urinary disturbances, elevated plasma creatinine levels, elevated urea levels, decreased total protein, decreased albumin, proteinuria, glucosuria, increased urinary sediment, urinary occult blood, sodium and fluid retention, hyperkalemia, acute kidney failure, decreased urine output, oliguria, urinary tract infections, interstitial nephritis, edema, peripheral edema, fatigue, fever, facial edema, syncope, weight loss, weight gain, axillary pain, breast pain, arthralgia, low back pain, axillary pain, chest pain, stiffness, lower limb weakness, decreased female reproductive capacity, dehydration

This medication is sensitive to light and should be stored in a container that prevents light exposure. Additionally, it should be stored at room temperature between 1 to 30 degrees Celsius. This ensures the effectiveness and safety of the medication.

Appearance

A hard capsule of dark green color filled with a light yellow substance.

Package unit

30 capsules/bottle, 300 capsules/bottle